Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

How Do Serum Zonulin Levels Change in Gestational Diabetes Mellitus, Pregnancy Cholestasis, and the Coexistence of Both Diseases

Bibliographic Data

ID15512184
AuthorsHuri GÜVEY (0000-0002-8603-6981, Turkey, corresponding author), Samettin Çelik (0000-0002-6407-1129, Samsun University), Canan Soyer Çalışkan (0000-0002-9889-5249, Samsun University), Zehra Yılmaz (0000-0002-6980-6470, Obstetrics and Gynecology, Private Office, Samsun 61420, Turkey), Merve Yılmaz (0000-0002-1434-6120, Turkey), Özlem Erten (0000-0002-3178-8297, Sağlık Bilimleri Üniversitesi), Andrea Tinelli (0000-0001-8426-8490, Moscow Institute of Physics and Technology)
Year2021
Volume18
Issue23
Pages12555-12555
Publication date2021-11-29
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph182312555
PMID34886280
OpenAlexW3215024410
LanguageEN
Citations received1
References cited34

We investigated the question of how serum zonulin levels change in intrahepatic cholestasis of pregnancy (ICP) and gestational diabetes mellitus (GDM) and, in the case of the coexistence of ICP and GDM, evaluated the eventual increase in zonulin plasmatic levels. Participants were enrolled for the study between 25 February 2021 and 20 August 2021. The prospective case-control study included: group 1 of 95 pregnant women diagnosed with ICP; group 2 of 110 pregnant women diagnosed with GDM; group 3 of 16 women diagnosed with both GDM and ICP; group 4 of 136 healthy pregnant women as the control group. The groups were compared in terms of age, body mass index (BMI), gravidity, parity, gestational week of delivery, plasma zonulin levels, delivery type, birth weight, first- and fifth-minute APGAR scores, newborn intensive care unit (NICU) admission, and meconium staining of amniotic fluid parameters. The results suggested that the plasma zonulin levels of ICP (group 1), GDM (group 2), and GDM with ICP (group 3) patients were higher than those of the healthy pregnant women of group 4 ( p < 0.001). Among the patient groups, the highest median plasma zonulin levels were found in group 3 (110.33 ng/mL). Zonulin levels were also associated with the severity of ICP and adverse pregnancy outcomes. High serum zonulin levels were related to GDM, ICP, and adverse perinatal outcomes. The coexistence of GDM and ICP led to higher serum zonulin concentrations

Amniotic fluid · Amniotic fluid index · Apgar score · Body mass index · Cholestasis of pregnancy · Diabetes mellitus · Fetus · Gestation · Gestational age · Gestational diabetes · Obstetrics · Pregnancy · Gestational Diabetes Research and Management · Medicine · Pancreatitis Pathology and Treatment · Pregnancy and Medication Impact · Endocrinology · Internal Medicine

  • Colestasis intrahepática en el embarazo

    Open Access•Shelsy Ramírez Perera, Francine Gutiérrez Fernández•LATAM Revista Latinoamericana de…•2023

  • Standards of Medical Care in Diabetes—2014

    American Diabetes Association•Diabetes Care•2014

  • Standards of Medical Care in Diabetes—2013

    American Diabetes Association•Diabetes Care•2013

Citations per year0.33
Citation span2023 - 2023 (1)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae